Researchers in South Africa say the first COVID-19 vaccine trial on the African continent is set to get underway on Wednesday. The University of the Witwatersrand says the vaccine developed by University of Oxford researchers is already being evaluated in a large trial in the UK and a similar trial is beginning in Brazil. The announcement came hours after South Africa reported that total coronavirus cases in the country surpassed 100,000 as of Tuesday. South Africa accounts for almost one-third of the infections on the African continent. The South Africa vaccine trial aims to enroll 2,000 participants. The first are to get vaccinated this week in Gauteng province, home of economic hub Johannesburg and the capital, Pretoria. Others will be vaccinated in the hot spot of Western Cape province. Shabir Madhi, who leads the trial, said it begins as South Africa enters winter and the flu season and as pressure increases on hospitals. South Africa has become a COVID-19 model for the continent in many ways since it confirmed its index case on 5th March, 2020. From the area of testing through to record number of recoveries, South Africa has been praised for pro-activeness in combating the virus.
SOURCE: AFRICA NEWS
More Stories
The Marshall Nature Reserve Gives a Different Glimpse of the Sudanese Capital
The Journey of Moving Tanzanians Around
Correcting Kinshasa’s Commodity Crisis
Can African Leaders Rate Themselves?
First Black African to Win Grand Tour Stage
Financing Dangote’s Fertiliser Dream Tougher than Expected
This is a Moment for the Women of Kenya
US Support in Somalia Couldn’t Have Come at a Better Time
A Symbol of Sudan’s Resistance
Families of Trapped Miners in Limbo
Google Translate Announces an Addition of 10 Languages Spoken in Africa
All Four Tourists Reported Missing in the Fish River Canyon have been Accounted For